Clinical trial · Interventional
Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Purpose Project intervention is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy. The goal of the intervention is to provide participants with information, tools, and support that help them move towards reclaiming a sense of self-grounded purpose in daily life. The study will use a convenience sample of women with breast cancer to evaluate the feasibility of the Purpose Project intervention in terms of demand/acceptability, implementation, and limited-efficacy testing. Findings will be used to inform a later study to evaluate the efficacy of the Purpose Project intervention.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Purpose Project | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Purpose Project Group
- description
- Group receiving Purpose Project intervention.
- interventionNames
- Behavioral: Purpose Project
Primary outcomes (1)
- measure
- Change in psychological well-being
- timeFrame
- Will be administered at Week 0 (pre-testing) and at Week 12 (session 8).
- description
- Using the Psychological Scales of Wellbeing questionnaire (Ryff, 1989; Ryff, \& Keyes, 1995), psychological wellbeing pre- and post- intervention will be tracked.
Secondary outcomes (11)
- measure
- Recruitment
- timeFrame
- Up to 1 month after IRB approval
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: 1. Between 25 and 74 years of age 2. Completed chemotherapy and/or radiation treatment for Stage 1, 2, or 3 breast cancer up to 5 years prior to study enrollment 3. English speaking 4. Graduated from high school 5. Able to see, hear, speak (with or without assistive devices) 6. Able to provide own transportation to sessions 7. Willing and able to commit to attend all 8 intervention sessions, 2 testing sessions, and the one-to-one interview that occurs after completing the 8 intervention sessions. Exclusion Criteria: 1. Stage 4 breast cancer or any other stage 4 cancer 2. Actively receiving chemotherapy or radiation treatments for cancer. (However, patients may be on Herceptin and/or endocrine treatment and participate in the study.) 3. History of neurologic disorder (such as stroke or brain injury) with residual impairments that likely interfere with learning 4. Any medical condition (physical or mental health) that interferes with the performance of everyday activities and roles.
References
Publications (0)
Data not yet available